Profile
EKSO ISRG BDX BDXA ALC RMD
Company Name Ekso Bionics Holdings, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $8.04M $191.29B $49.98B $48.71B $43.43B $37.41B
Employees 0.06K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Scott G. Davis Gary S. Guthart Mr. Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
EKSO ISRG BDX BDXA ALC RMD
Quant Rating Score 2 3 3 5 3 3
Quant Rating Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
EKSO ISRG BDX BDXA ALC RMD
Last Close $3.29 $543.41 $172.25 $59.24 $88.28 $258
High 52 $4.67 $610.45 $249.08 $59.24 $100.76 $258
Low 52 $0.25 $416.14 $165.15 $59.24 $82.73 $186.94
Price vs. 52 Week High -29.55 % -10.98 % -30.85 % 0 % -12.39 % 0 %
Price vs. 52 Week Low 1216 % 30.58 % 4.3 % 0 % 6.71 % 38.01 %
Total Return
EKSO ISRG BDX BDXA ALC RMD
1 Month Return 989.4 % -1.62 % -0.2 % 0 % 2.72 % 5.4 %
3 Month Return 711.14 % 9.48 % -23.8 % 0 % -4.77 % 16.06 %
6 Month Return 439.34 % 4.11 % -24.08 % 0 % 3.99 % 12.82 %
9 Month Return 196.4 % 12.1 % -28.73 % 0 % -10.94 % 8.06 %
YTD Return 439.34 % 4.11 % -24.08 % 0 % 3.99 % 12.82 %
1 Year Return 216.35 % 24.57 % -24.87 % 0 % 0.24 % 38.01 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
EKSO ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 2.33 % 2.38 % 0.38 % 0.83 %
Dividend Paid and Capex Coverage Ration (TTM) -32.73 % 2.77 % 1.77 % 1.77 % 4.15 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) -2.09 % - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
EKSO ISRG BDX BDXA ALC RMD
Asset Growth -7.84 % 8.54 % 8.54 %
Gross Profit Growth 4.76 % 11.69 % 11.69 %
Revenue Growth -1.94 % 4.16 % 4.16 %
Revenue 3 Year -3.6 % -0.51 % -0.51 %
Revenue 5 Year -69.37 % 8.72 % 8.72 %
Revenue 10 Year -83.88 % 59.37 % 59.37 %
EBIT Growth 25.75 % 19.82 % 19.82 %
Net Income Growth 25.45 % 14.89 % 14.89 %
Net Income 3 Yeari Growth Per Share 18.74 % -18.63 % -18.63 %
Net Income 5 Yeari Growth Per Share 76.96 % 30.19 % 30.19 %
Net Income 10 Yeari Growth Per Share 98.39 % -4.02 % -4.02 %
Operating Income Growth 30.78 % 13.55 % 13.55 %
Operating Cash Flow Growth (CFG) 18.32 % 27.07 % 27.07 %
Operating 3 Year CFG 46.62 % -18.4 % -18.4 %
Operating 5 Year CFG 85.16 % 6.25 % 6.25 %
Operating 10 Year CFG 96.86 % 45.28 % 45.28 %
EPS Growth 49.09 % 18.31 % 18.31 %
EPS Diluted Growth 49.09 % 18.62 % 18.62 %
Book Value Per Share -30.67 % -0.85 % -0.85 %
Share Holder 3 Year Equity Growth Per Share -79.35 % 9.16 % 9.16 %
Share Holder 5 Year Equity Growth Per Share -55.55 % 13.89 % 13.89 %
Share Holder 10 Year Equity Growth Per Share -97.33 % 241.78 % 241.78 %
Dividend Per Share Growth - -2.44 % -2.44 %
Dividend 3 Year Growth Per Share - 4.79 % 4.79 %
Dividend 5 Year Growth Per Share - 4.14 % 4.14 %
Dividend 10 Year Growth Per Share - 74.3 % 74.3 %
Debt Growth -16.53 % 26.65 % 26.65 %
Free Cash Flow Growth 19.06 % 45.25 % 45.25 %
Updated On 31 Dec 2024 30 Sep 2024 30 Sep 2024
Profitability
EKSO ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 53.39 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM -39.52 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM -82.5 % 15.52 % 5.86 % 5.86 % 6.95 % 25.18 %
Return on Capital Employed TTM -56.75 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 100 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 101.39 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM -60.67 % 28.2 % 11.33 % 11.33 % 15.22 % 32.1 %
Cash Flow To Debt Ratio TTM -148.57 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 2.72 6.46 6.89 6.89 5.35 5.53
Payables Turnover TTM 4.09 10.39 - - 5.25 9.36
Inventory Turnover TTM 1.65 1.85 3.11 3.11 1.89 2.41
Fixed Asset Turnover TTM 820.96 % 181.6 % 313.98 % 313.98 % 202.74 % 729.93 %
Asset Turnover TTM 64.24 % 45.34 % 38.31 % 38.31 % 32.06 % 66.36 %
Operating Cash Flow Per Share TTM -0.33 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -0.33 4.88 8.98 8.98 3.47 10.66
Cash Per Share TTM - 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM -47.57 % 31.34 % 15.81 % 15.81 % 21.14 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.35 % 63.9 % 78.51 % 78.51 % 81.86 % 94.64 %
Cash Flow Coverage Ratios TTM -148.57 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -0.96 109.6 19.3 18.91 25.25 23.92
Price To Operating Cash Flows Ratio TTM -10.19 69.86 15.25 14.94 20.69 22.65
Price Cash Flow Ratio TTM -10.19 69.86 15.25 14.94 20.69 22.65
Income Statement (TTM)
EKSO ISRG BDX BDXA ALC RMD
Revenue $0.02B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $0.01B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 53.06% 67.46% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.01B $2.81B $4.82B $4.82B $2.68B $1.53B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -0.56 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
EKSO ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.01B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.01B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0B $6.89B $0.45B $0.45B $0.75B $0.17B
Total Debt $0.01B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.03B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
EKSO ISRG BDX BDXA ALC RMD
Net Income $-0.01B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $2.08B $1.4B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.3
ALC Alcon Inc. 88.28
ANGO AngioDynamics, Inc. 9.92
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 156.43
ATRC AtriCure, Inc. 32.77
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 30.78
BAX Baxter International Inc. 30.28
BDX Becton, Dickinson and Company 172.25
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.01
BLFS BioLife Solutions, Inc. 21.54
COO The Cooper Companies, Inc. 71.16
DXR Daxor Corporation 9.79
FEMY Femasys Inc. 0.9658
GCTK GlucoTrack, Inc. 6
ETFs With Exposure to EKSO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 303.93
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 135.04
VXF Vanguard Extended Market Index Fund 0 192.71
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 103.4
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 103.38
DFUS Dimensional U.S. Equity ETF 0.0000235 67.02
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000288 35.84
VTSAX Vanguard Total Stock Market Index Fund 0 148.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.26
VITSX Vanguard Total Stock Market Index Fund 0 148.03
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.27
VEMPX Vanguard Extended Market Index InstlPlus 0 360.93
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 277.69
Unlock